Baino B; Department of Clinical Medicine and Surgery, Naples, Italy.
D’Alto M; Dimopoulos K; Bocchino M
Chest. 170(5):1565-1575, 2026 Nov.
TOPIC IMPORTANCE: Eisenmenger syndrome (ES) is an advanced form of
pulmonary arterial hypertension associated with congenital heart disease,
marked by pulmonary vascular disease and right-to-left or bidirectional
shunting. Although vascular remodeling is central, lung involvement is
still underrecognized.
REVIEW FINDINGS: This review describes pulmonary and related aspects that
accompany ES and their contribution to symptoms, prognosis, and
management. A restrictive pattern is common on function testing, whereas
obstructive defects and bronchial hyperresponsiveness may occur even
without typical risk factors. Diffusion impairment related to vascular
disease is frequent and linked to reduced exercise capacity and worse
survival. Exercise intolerance reflects the combined effects of pulmonary
vascular disease, shunt-related hypoxemia, and ventilation-perfusion
mismatch, which increase ventilatory demand, promote early anaerobic
metabolism, and reduce peak oxygen uptake. Cardiopulmonary exercise
testing and the 6-minute walk test provide prognostic information, with
peak oxygen consumption emerging as the strongest predictor. An additional
complication is marked pulmonary artery dilatation, predisposing to in
situ thrombosis and compressive syndromes. Hemoptysis, often bronchial in
origin, requires a structured emergency pathway. Lower respiratory tract
infections are relatively common and may increase morbidity and mortality.
Long-term oxygen therapy provides limited benefit because hypoxemia is
mainly shunt-driven; supervised rehabilitation is safe and can improve
functional capacity. In advanced disease refractory to treatment,
bilateral lung or heart-lung transplantation remains the only definitive
option, despite suboptimal outcomes.
SUMMARY: ES is a multisystem disorder in which pulmonary abnormalities
meaningfully influence symptoms and prognosis; systematic lung assessment
can refine risk stratification and support individualized supportive care
by integrated cardiology-pulmonology teams.